U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.4307_4320del (p.Leu1436fs) AND not specified

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 12, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000780136.1

Allele description [Variation Report for NM_000492.4(CFTR):c.4307_4320del (p.Leu1436fs)]

NM_000492.4(CFTR):c.4307_4320del (p.Leu1436fs)

Genes:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
LOC111674477:CFTR intron 23 enhancer [Gene]
Variant type:
Deletion
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.4307_4320del (p.Leu1436fs)
HGVS:
  • NC_000007.14:g.117666972_117666985del
  • NG_016465.4:g.206189_206202del
  • NG_056133.2:g.1378_1391del
  • NM_000492.4:c.4307_4320delMANE SELECT
  • NP_000483.3:p.Leu1436fs
  • LRG_663:g.206189_206202del
  • NC_000007.13:g.117307026_117307039del
  • NM_000492.3:c.4307_4320del14
Protein change:
L1436fs
Links:
dbSNP: rs1562929573
NCBI 1000 Genomes Browser:
rs1562929573
Molecular consequence:
  • NM_000492.4:c.4307_4320del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000917181Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Oct 12, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000917181.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: CFTR c.4307_4320del14 (p.Leu1436HisfsX21) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g., p.Ser1455X and p.Gln1476X). This variant is likely to disrupt the ABC transporter-like domain at the C-terminal of the encoded protein. The variant was absent in 245714 control chromosomes (gnomAD). To our knowledge, no occurrence of c.4307_4320del14 in individuals affected with Cystic Fibrosis and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 26, 2023